UTHR Stock Metrics & Key Financial Ratios

Home Back to 8 Pillar SearchUnited Therapeutics Corp (UTHR)

United Therapeutics Corp (UTHR)

NYSE American - Real Time Price

Currency in USD

ㅤ

About United Therapeutics Corp

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

Home Back to 8 Pillar SearchUnited Therapeutics Corp (UTHR)

United Therapeutics Corp (UTHR)

NYSE American - Real Time Price

Currency in USD

ㅤ

About United Therapeutics Corp

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic